These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 676870)
41. Determinants of resistance to various aminoglycoside antibiotics. Pisano A; Mattina R; Nicoletti G Antibiotica; 1977 Mar; 14(1):58-72. PubMed ID: 879719 [No Abstract] [Full Text] [Related]
42. [Modern trends in antibiotic therapy of difficult infections: amikacin sulfate. A meeting held in Naples with Professor Fernando De Ritis as Chairman]. Fabbrocini V Minerva Med; 1980 Jan; 71(1):58-61. PubMed ID: 7354926 [No Abstract] [Full Text] [Related]
43. Comparison of 5-episisomicin (Sch 22591), gentamicin, sisomicin, and tobramycin in treatment of experimental Pseudomonas infections in mice. Goering RV; Sanders CC; Sanders WE Antimicrob Agents Chemother; 1978 Dec; 14(6):824-8. PubMed ID: 742870 [TBL] [Abstract][Full Text] [Related]
44. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing. Dager WE; King JH Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944 [TBL] [Abstract][Full Text] [Related]
46. Choice of antibiotics for empiric treatment of serious infections. Gupta BL; Singh S; Rattan A; Bhujwala RA J Assoc Physicians India; 1994 Feb; 42(2):124-5. PubMed ID: 7860472 [TBL] [Abstract][Full Text] [Related]
47. [Pathogenic flora in hematology patients. Gram-negative germs and their in vitro sensitivity to antibiotics]. Cortelezzi A; Radaelli F; Savarè M Minerva Med; 1982 Feb; 73(5):161-70. PubMed ID: 7063132 [TBL] [Abstract][Full Text] [Related]
48. Recent advances in antibiotics. McAllister TA Scott Med J; 1976 Oct; 21(4):210-7. PubMed ID: 793006 [No Abstract] [Full Text] [Related]
49. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics. Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865 [No Abstract] [Full Text] [Related]
51. Comment on: Aminoglycoside drugs in clinical practice: an evidence-based approach. Keuleyan EE; Kirilov KG J Antimicrob Chemother; 2009 May; 63(5):1081-2; author reply 1082-3. PubMed ID: 19252182 [No Abstract] [Full Text] [Related]
52. [Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)]. Lode H; Grunert K; Kemmerich B; Koeppe P Adv Clin Pharmacol; 1978; 15():35-44. PubMed ID: 676877 [TBL] [Abstract][Full Text] [Related]
53. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection]. Navashin PS Antibiotiki; 1982 Dec; 27(12):26-9. PubMed ID: 6819812 [TBL] [Abstract][Full Text] [Related]
54. [Practical aspects of therapy with aminoglycoside antibiotics]. Gerber AU Ther Umsch; 1985 Aug; 42(8):498-502. PubMed ID: 4049305 [No Abstract] [Full Text] [Related]
55. Cost-effective aminoglycoside therapy in surgical patients. Gladen HE Am J Med; 1986 Jun; 80(6B):228-33. PubMed ID: 3089004 [TBL] [Abstract][Full Text] [Related]
56. Gentamicin in 1978. Appel GB; Neu HC Ann Intern Med; 1978 Oct; 89(4):528-38. PubMed ID: 358884 [TBL] [Abstract][Full Text] [Related]
57. Clinical pharmacology of aminoglycosides. Part 2. Houdeshell JW; Lamendola JF; McCracken JS Mod Vet Pract; 1982 Sep; 63(9):707-10. PubMed ID: 7188280 [No Abstract] [Full Text] [Related]
59. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility. Ismaeel NA Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714 [TBL] [Abstract][Full Text] [Related]